Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 22
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Enlivex Ltd
ENLV
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.2022
-0.0215
-9.61%
Ult. Agg.: Oct 21, 7:23 PM
$0.2166
-0.0071
-3.17%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Enlivex Analyst Price Targets - Benzinga
Enlivex Analyst Price Targets
Wall Street analyst price targets and consensus rating for Enlivex (ENLV).
Analyst Ratings News
PRO
HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $80
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and raises the price target from $20 to $80.
Benzinga Newsdesk
PRO
HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $20
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and raises the price target from $13 to $20.
Benzinga Newsdesk
Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum
Enlivex's RAIN token begins trading on KuCoin as analysts raise price targets, citing growing prediction markets and token burn mechanics.
Vandana Singh
PRO
HC Wainwright & Co. Maintains Buy on Enlivex Therapeutics, Raises Price Target to $13
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and raises the price target from $7 to $13.
Benzinga Newsdesk
PRO
D. Boral Capital Downgrades Enlivex Therapeutics to Hold
D. Boral Capital analyst Jason Kolbert downgrades Enlivex Therapeutics (NASDAQ:ENLV) from Buy to Hold.
Benzinga Newsdesk
PRO
D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target
D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ:ENLV) with a Buy and maintains $13 price target.
Benzinga Newsdesk
Crea una watchlist
GRATIS: Segui le azioni e criptovalute con le migliori notifiche di internet
Clicca per iniziare
People Also Watch
AbbVie Inc
NYSE:ABBV
$284.75
-0.02%
Amgen Inc
NASDAQ:AMGN
$438.11
-0.05%
Gilead Sciences Inc
NASDAQ:GILD
$153.71
0.09%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
$524.52
-%
Moderna Inc
NASDAQ:MRNA
$246.2
0.16%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
$805.67
-%
Natera Inc
NASDAQ:NTRA
$413.38
-%
argenx SE
NASDAQ:ARGX
$889.25
-0.09%
BeOne Medicines Ltd
NASDAQ:ONC
$388.91
0.63%
Revolution Medicines Inc
NASDAQ:RVMD
$193
-0.66%
Mostra tutte le 10 aziende correlate
